Tuesday, August 4, 2026

Consensus expects $0.82 EPS on $836M revenue, and Entegris has beaten EPS in 4 of the last 6 quarters. The signals — TSMC raising capex, the wafer-start (MSI) forecast moving from mid-single to mid/high-single-digit growth, and record filtration results — suggest they could beat again. The question is whether management raises or reaffirms the 2026 outlook, keeps gross margin near 46.9%, and makes the Q3 ~5% sequential growth guide look credible. The single most important number is the Q3 sequential revenue comment; a softer number could outweigh a Q2 EPS beat.

Consensus (the average analyst estimate) for Q2 is $1.07 earnings per share (EPS) on $1.36B revenue, versus $1.08 EPS and $1.3B revenue in Q1. No separate quarterly guide is shown in the source; the raised full-year ranges are the guideposts. With three straight beats, 17% organic growth last quarter, and TSMC and ASE both raising, Qnity could beat again. The specific question is whether management raises the full-year ranges a second time and whether adjusted EBITDA margin holds near 31.3%. The one number to watch is Q2 organic growth: if it slips below mid-teens, the acceleration story weakens even if EPS beats.

Consensus for the August 4 report is $2.32 EPS on $324M revenue, versus last quarter's $2.14 EPS on $303M. Management has raised full-year sales growth to 10-14% and adjusted EBITDA to $315-330M. Signals suggest Enpro could beat that consensus, but the key question is whether management raises the full-year guide again; watch AST second-half language — if it softens, the stock could drop despite a good print. The number to watch is the adjusted EBITDA range, $315-330M, and whether it moves up.

Consensus for the August 4, 2026 report is $1.06 EPS on $3.14B revenue, roughly the TTM run-rate divided by four. Last quarter's EPS was $0.90, so a repeat would be about 15% below consensus. Management has not given a quarterly revenue or EPS guide; its stated guide is 2026 growth above 2025, 12.5% distribution growth for 2026-2027, and a 1.3x coverage floor. Beat history is mixed — three of the last six quarters. The question going in is whether management repeats the 2026 growth-above-2025 promise and keeps project timing. The signals do not rule out a beat, but the reward depends on that repetition and timing. The single number to watch is the NGL price sensitivity: $20M of annual segment EBITDA for every $0.05 move in NGL prices, and whether the Q1 $56M hedge loss still reverses as expected.

Consensus expects Q2 2026 EPS of $6.22 on revenue of $19.34B. Management has not given a specific Q2 revenue guide in the source; it is working from a 2026 framework of low-double-digit sales growth, an adjusted operating margin (a profitability measure after certain adjustments) above the January expectation, and MP&E (Machinery, Power & Energy) free cash flow above $9.5B. The signals suggest they could beat, but the stock fell 8.5% after last quarter and good results can be sold in this layer. The specific question is whether management raises the full-year sales or margin path again. The number to watch is power-generation sales-to-users: Q1 was +48% y/y; a sharp deceleration could make the premium multiple harder to justify.

Consensus expects $0.69 EPS on $228 million revenue, versus $0.53 EPS on $214 million last quarter. The source doesn't include SLAB's official Q2 guide, so the first thing to check is whether management's commentary supports that step-up. The ecosystem signals — strong beats from competitors, raised guidance from foundry partner TSMC, and an above-seasonal outlook from TI — suggest SLAB could beat, but the layer's negative stock reaction pattern warns that even a beat might not lift the stock. The single most important number is the CGM contribution: management promised a path to 10% of revenue in the first half of 2026, and confirming that would validate the growth story. A miss on that promise, or guidance that doesn't keep pace with consensus, could outweigh an EPS beat.

The Q2 consensus is $0.28 EPS on $340M revenue; USAC has beaten EPS in only 2 of the last 7 quarters. Management's public guide is full-year adjusted EBITDA of $770–800M and distributable cash flow of $480–510M, with no quarterly revenue guide. The signals — record revenue per horsepower, tight engine supply, and new in-house manufacturing — suggest they could beat. The key question is whether management holds, narrows, or raises the full-year range, and the number to watch is revenue per average active horsepower per month, which was $22.73 last quarter. If that slips, the pricing story weakens.

Consensus for the quarter is $0.26 EPS on $279M revenue; management has not given a separate Q2 guide. Full-year, management guides 25–27% revenue growth and 37–39% adjusted EBITDA margin, while consensus sits at $1,150.9M revenue and $1.23 EPS for 2026. The beat streak of 7 straight quarters, the RPO preannouncement, and the competitor commentary suggest DOCN could beat, and the main question is whether management raises the full-year revenue guide above 27% or holds it. The one number to watch is RPO: if it lands well above $800M, that could support the 2027 50%+ growth promise; if it lands barely above $800M, the market could treat it as no new upside.

Consensus expects $0.21 EPS on $836M revenue. Management has not guided the quarter; its full-year 2026 guide is base revenue of $3.15-$3.45B and base gross profit of $255-$285M. Confirmed customers' steady guidance, the large backlog, and the customer awards announced in May and June suggest CTRI could beat. The questions are whether management keeps or raises the full-year base gross profit guide and confirms the ~$300M Q2 data-center booking target. The single most important number is Q2 data-center awards: a clear shortfall would not break the quarter financially, but it would cool the AI/adjacent-market growth story.

Consensus for Tuesday's report is $3.38 adjusted EPS (earnings per share, adjusted for one-time items) on $2.24B revenue, compared to $3.30 last quarter. Management did not issue a separate Q3 guide in the source material; after Q2 it raised full-year organic growth to 5–9% and adjusted EPS to $12.50–$13.10. The signals suggest ROK could beat again. The specific question is whether management raises the full-year guide again, especially the adjusted EPS midpoint above $12.80. Watch organic sales growth: Q2 was +9%; a drop toward 5% could make the raised guide look fragile.

Consensus for Tuesday is $1.62 EPS on $1.23B revenue. Management's full-year guide is $5.75-$6.25 EPS, $350-$375M free cash flow, and +4% to +6% revenue growth; consensus FY EPS of $6.16 sits above the midpoint. The signals — record Industrial Motion revenue, a raised FY guide, and higher backlog — suggest TKR could beat. The question is whether management raises or narrows the FY range again and whether Engineered Bearings margin compression eases. The number to watch is Engineered Bearings adjusted EBITDA margin: it fell 120 bps year-over-year last quarter, and another drop would make the consensus EPS number harder to reach.

Consensus expects $1.83 EPS on $3.24B revenue for Q2. Management hasn't issued a specific Q2 revenue guide in the source material, but they did nudge HIP guidance to the low end of the prior range last quarter. The ecosystem signals — Dow raising, Olin pointing to capacity discipline — suggest Westlake could see supportive polyethylene and chlor-alkali conditions. The question is whether HIP volume recovers after weather-dented Q1 and whether PEM margins hold now that the $45M natural-gas headwind is behind them. The single most important number is PEM EBITDA: it was only $36M in Q1; if it doesn't improve meaningfully, the full-year EPS consensus of $3.47 looks hard to reach.

Consensus for the quarter is $1.76 adjusted EPS on $1.81B revenue. No specific total-company Q2 revenue guide appears in the source; management did guide Healthcare & Water to mid-single-digit organic growth in Q2 and kept the FY 2026 adjusted EPS range at roughly $7.05-$7.20 post-split, with consensus at $7.16. Seven straight beats and a reaffirmed FY guide suggest the company could beat again, but the chip-making layer shows stocks can fall even when numbers clear. The question is whether management holds or raises the FY guide and whether Water growth recovers from the Middle East shipping disruption. Watch Healthcare & Water organic growth: Q1 printed +3%, and a repeat below mid-single digits would put pressure on the full-year framework.

Consensus expects Q2 EPS of $0.10 on $160M revenue; management guided Q2 revenue of $150M–$170M and adjusted EBITDA of $28M–$33M, so revenue consensus sits at the midpoint. Full-year consensus revenue of $682.5M is labeled in one source as FY ending 2027-12-31, not a same-year compare to the FY2026 guide. The record BLAO, rising BESS backlog and Q1 beat suggest Q2 could land in the upper half of the range, but the company has beaten only 2 of the last 7 quarters. The key questions are whether management holds or raises the FY guide, whether gross margin starts moving up from 29.6%, and whether the ON.energy BESS ramp stays on schedule. Watch adjusted gross margin: flat at 29.6% or lower could push adjusted EBITDA toward the $28M low end rather than the $33M high end.

Consensus expects $1.55 EPS on $759M revenue. Management has not given a numeric Q3 guide but promised sequential growth from Q2's $731M revenue, $81M adjusted EBITDA and $1.23 EPS, and it reaffirmed FY2026 ranges of $340M-$360M EBITDA and $5.05-$5.55 EPS. The ecosystem signals suggest Atkore could beat consensus; the question is whether management keeps the back-half ramp language and how steel costs are tracking. Watch Q3 adjusted EBITDA relative to Q2's $81M — below that could put the full-year guide at risk.

Consensus for this quarter is $0.38 non-GAAP EPS on $854M reported revenue. Management promised a meaningful year-over-year step-up in operating margin (the share of revenue left after operating expenses) and EPS, plus a return to organic revenue growth (growth stripping out currency and deals) in Q2. Q1 organic revenue was -4.4%, but semi metrology and SciY bookings grew over 20%, and ASML's beat and raise supports the AI-adjacent story; those signals suggest they could beat. The main question is whether organic growth actually turns positive and whether management raises or keeps the FY26 guide of 4-5% reported revenue growth and 1-2% organic growth. The single most important number is organic revenue growth: another negative quarter could put the FY26 guide at risk.

Q2 consensus is $1.69 EPS on $2.91B revenue, and EXPD has beaten EPS for 7 straight quarters. Management did not provide a public Q2 forecast in the source material, so there is no company guide to compare with consensus. The signals — a stable quarterly report, a growing inferred AI-logistics footprint, and a seven-quarter beat record — suggest they could beat again, but the lack of confirmed AI revenue and no call transcript make that far from certain. The question going in is whether management puts a number on data-center/AI logistics or airfreight revenue; the number to watch is airfreight, 36% of 2025 revenue and gaining share in 2025. If that line misses or decelerates, the stock's EV/EBITDA — about 40% above its own historical median — leaves room for a negative reaction.

Consensus expects a loss of $0.24 per share on revenue of $32 million. Management has not given formal quarterly financial guidance; it guides through project milestones and NOI targets. Ecosystem signals suggest demand for CIFR's contracted HPC capacity is strong, but reported revenue is still shrinking Bitcoin mining, so a revenue miss is possible if mining declines faster than expected. The key question is whether management holds or raises the ~$787 million average annualized NOI target and keeps the Barber Lake tenant entry on track for later this year. Watch the NOI figure: a cut would signal delivery or pricing trouble, while a raise would suggest the AI lease book is becoming more valuable.

Consensus expects a loss of $0.04 per share; there is no revenue estimate. Management has not given financial guidance, so the real guide is operational: more offtake, camp expansion, and a construction timeline once federal approval arrives. NXE has missed the consensus per-share estimate for seven straight quarters, so the EPS bar is low but the milestone bar is high. The signals do not point clearly to a beat — the company has missed seven straight, and the power-generation layer has tended to sell good news. The question going in is whether management announces new offtake or narrows the approval timeline. The one number to watch is the remaining 1.5 Mlbs/yr of un-contracted offtake: a new contract that closes part of that gap could be a concrete positive, while another quiet quarter could leave the stock under pressure.

Consensus for Q2 2026 is $7.21 EPS on $9.33B revenue; management has not given a specific Q2 guide, but for FY2026 it guided revenue up 8-11% and EBITDA margin of 17.75-18.5%, with consensus FY revenue of $37.08B sitting inside the implied $36.4B-$37.4B range. The ecosystem signals and the power-gen order book suggest they could beat; the question is whether management raises the full-year guide again or holds it. Watch Power Systems growth - it was +19% YoY in Q1; if it stays near the +15-25% power-gen range, the AI story holds, while a sharp slowdown would likely pressure the stock.

Consensus for the upcoming Q2 print is $1.13 EPS on $931M revenue. Management's full-year guide is $3.3B–$3.5B revenue and $520M–$560M adjusted EBITDA, expected to trend toward the upper half; full-year consensus revenue of $3.60B is about 3% above the high end and 6% above the midpoint. The signal mix — record backlog, strong volume growth, and competitor beats — suggests KNF could beat the quarterly number. The specific question is whether management raises the full-year revenue range toward consensus. One number to watch: Q1 mix-adjusted aggregates pricing was +4.1% versus +1% as-reported; if mix-adjusted pricing slips below mid-single-digit on a same-plant basis, the full-year pricing promise could be at risk, and the stock could stay under pressure.

Q2 consensus is $0.37 EPS on $280M revenue. The source doesn't include management's explicit Q2 guide, so the comparison is to consensus. The signals — 17% revenue growth, 21% industrial growth, 1.0 book-to-bill, and a strong medical backlog — suggest IPG could beat. The specific question is whether Advanced Solutions turns positive after -5% in Q1; that's the number to watch. A second negative quarter could weaken the AI/defense/medical story, while a positive number could signal the higher-growth segment is starting to contribute.

Consensus for Q2 is a -$0.04 EPS loss on $14 million revenue, a smaller loss than Q1’s -$0.07. Management does not give quarterly guidance; its full-year sales-proceeds guide is about $83.2 million. Production signals — 110,000 lbs captured in Q1, April drumming of 57,000 lbs, and Shirley Basin now authorized — suggest the quarter could beat on volume, but the company has not beaten consensus in six quarters. The question is whether management raises the full-year guide again and whether cash cost stays near $37.50; watch cash cost per pound, because it fell 13% last quarter and a reversal would narrow the margin built into the $71/lb realized price.

Consensus expects $1.99 EPS on $1.95B revenue, and AME has beaten EPS for 7 straight quarters. Management guided Q2 adjusted EPS to $1.96-$2.00 and sales growth up high single digits, so consensus sits at the upper half of the EPS range. The signals — record backlog, 1.14x book-to-bill, Q1 organic order growth of +22% — suggest AME could beat or land near the top. The question is whether management raises the FY2026 organic-sales guide again and whether core margin stays near 28%. Watch organic order growth: Q1 was +22%; if it falls toward low single digits, the backlog story weakens even if EPS beats.

Consensus for Q2 is $1.30 EPS on $7.66B revenue, about 23% of the trailing-twelve-month revenue base and below Q1's adjusted $1.93. Management didn't give a Q2-specific guide, but reaffirmed FY2026 EPS of $6.55–$6.80 and long-term 5–7% EPS growth with top-half performance starting in 2028. The supplier signals and ESA growth suggest Duke could beat, but the 73%/35% layer gap means a beat alone might not lift the stock. The specific question is whether management adds any new signed ESAs beyond 7.6 GW and keeps the 2026 and 2028 promises intact. The number to watch is total signed data-center ESAs: flat at 7.6 GW leaves the AI story unchanged, while a move higher could add evidence for the 2028 top-half growth path.

Consensus is $0.38 EPS on $27.71B revenue for Q2. Management's public anchor is full-year 2026 adjusted EBITDA of $18.2B–$18.6B, raised after Q1. ET has beaten only 1 of the last 7 quarters, so the setup is not a sure thing, but strong Q1 volumes, raised full-year guidance, and confirmed competitors beating suggest the company could beat. The question going in is whether management raises the full-year guide again or holds it, and whether the AI project timeline stays intact. Watch adjusted EBITDA: Q1 came in at $4.9B and beat internal plan by about $500M; if Q2 falls well below that run-rate, the full-year raise could look like it was pulled forward.

Consensus for the print is $0.79 EPS on $2.66B revenue. Management hasn't given a separate Q2 guide; the full-year EPS range is $4.28–$4.40, and they've beaten six of the last seven quarters. The signals — on-track capex, a 95.5% nuclear capacity factor, PSEG Power earnings up year over year — suggest they could beat. The question is whether management holds the full-year range and gives a concrete update on the 11 GW data-center pipeline and hyperscaler contracting. The one number to watch is regulated capex: Q1 was ~$800M, and the ~$4.2B full-year target implies ~$1.13B per quarter for the rest of the year; a Q2 figure below that pace could signal slippage in the growth plan.

Consensus for this print is $1.46 EPS on $1.40B revenue; management’s explicit guide is 2026 EPS of $4.55–$4.75. The signals — TSMC’s capex raise, Q1 C&I growth of +14.6%, and pre-funded equity — suggest PNW could land close to consensus. The question is whether management keeps the 2026 EPS range and holds the 5–7% long-term sales-growth story. The number to watch is weather-normalized C&I sales growth: if it stays near double digits, the load narrative holds; if it snaps to mid-single digits, the market could start discounting the long-term target.

Consensus expects -$0.55 EPS on $79M revenue. Management has not given a quarterly revenue or EPS guide in the source material; the public guide is around the AI contracts — ~$1.1B annual NOI once stabilized and first data halls in Q2 2027. The ecosystem and pipeline signals suggest they could beat the revenue number, but EPS likely stays negative because of digital-asset mark-to-market losses. The question is whether management reaffirms delivery timing and NOI targets, and whether the 8.4 GW pipeline converts into new leases. The one number to watch is any change to River Bend or Beacon Point delivery timing, because a slip could push the contracted revenue story further out.

Consensus is $1.69 EPS on $7.31B revenue for the quarter, versus $1.48 reported last quarter. Management hasn't given a specific Q2 guide; it reaffirmed full-year 2026 guidance in May. The ecosystem signals and the layer's high bar suggest NRG could beat, but the question going in is whether a beat is enough without progress on large-load data-center deals. The number to watch is the 2026 EBITDA midpoint at ~$5.575B. A second tell is whether management keeps the at-least-1GW signed data-center contract target for 2026; if that target slips, the stock could sell off even on a good EPS print.

Consensus expects $0.76 EPS on $455M revenue. Management guided Q2 revenue to the mid-$400M range, so consensus sits near the midpoint of the guide. The ecosystem signals and $1.3B in contracted SiPho revenue suggest they could beat, but the stock is down about 19% since last earnings despite a seven-quarter beat streak and sits 31-40% below its high, so the bar is about whether management raises the 2028 financial model and confirms the SiPho capacity ramp. The one number to watch is SiPho revenue growth — it tripled year over year in Q1, and if that pace slows or the capacity ramp slips, the multiple could compress hard.

Consensus for this print is $0.15 EPS (earnings per share) on $3.41B revenue; last reported EPS was $0.10, and Gerdau has not beaten consensus in seven straight quarters. Management's most recent operational guide is Brazil EBITDA margin around 7%, South America margin recovering to mid-teens in 2026, stable North America profitability, and 2026 capital spending (CapEx) of BRL4.7B. The US competitor results and 90-day backlog suggest North America could keep carrying the quarter, but Brazil is the swing factor. The question is whether management can hold Brazil near 7% margin and give a timeline for the Miguel Burnier cost benefit. The single number to watch is Brazil EBITDA margin: it was around 7% last quarter, and a print below that could signal import pressure is still not easing.

Consensus — the average analyst estimate — for Q2 is $1.14 EPS (earnings per share) on $1.08B revenue. Management hasn't given a Q2 number; its full-year guide is $4.3–$4.4B revenue and $345–$360M EBITDA. The competitor signals and record backlog suggest ECG could beat, but the layer's post-earnings selling and Q1's one-time margin help cut the other way. The question is whether management keeps the raised guide and whether Q2 EBITDA margin holds near the ~8% legacy assumption after Q1's 8.6%. The one number to watch is EBITDA margin: below ~8% could put the full-year EBITDA range at risk.

Consensus for this print is $1.68 EPS on $4.80B revenue — about a quarter of trailing revenue. Management's open FY2026 promises include roughly 28% adjusted segment EBITDA margin, $3.5–3.6B free cash flow, 10%-plus ACV growth, and underlying sales growth cut to about 3%. The ecosystem signals and funnel suggest EMR could beat consensus, but the layer's reaction to beats suggests the stock might not move up even on a beat. The question is whether management raises the EPS outlook again or holds. The single most important number is Ovation order growth: +41% in Q2 after +74% in Q1; a sharp slowdown could undermine the AI-power story.

Consensus for the early-August report is $0.10 EPS on revenue of $22M, while management guided revenue of $20.5M to $22.5M and low double-digit adjusted EBITDA margins, with AI above 40% of TPS revenue. Order momentum and backlog suggest revenue could land near the top of the range. But the stock fell 15.8% after the last report despite a strong quarter, so a beat alone might not be enough. The question going in is whether AI mix delivers on the >40% promise; missing it could undercut the acceleration story, while meeting it supports the September product launch and a rising AI share of total revenue.

Consensus for Q2 is $0.44 EPS on $186M revenue. Source material does not show a Q2 revenue guide; management's disclosed guides are Q2 OpEx of $64–67M and full-year gross margin of 69.5% ±1%. The suppliers' beat-and-raise pattern and the backlog comment suggest LSCC could beat that consensus. The specific questions are whether management keeps the ~25%-of-2026-revenue AI target, confirms channel inventory under two months, and gives a first read on AMI contribution after the July 27 close. Channel inventory is the one number to watch: above two months would signal the distributor channel is not clearing as fast as promised.

Analyst consensus is -$0.10 EPS on $418M revenue. Management guided Q2 revenue growth of 2-8% y/y and gross margin up 130-170 basis points sequentially from Q1's 19.8% — that range would land around 21.1-21.5%. The signals suggest they could beat the consensus revenue number if the energy ramp shows up in Q2, but energy comps are tougher and PeopleSolutions organic growth was -7% last quarter. The key question is whether management keeps the gross-margin promise and confirms the PeopleSolutions margin rebound; if gross margin doesn't show the guided step-up, adjusted EBITDA could stay negative and the recent stock recovery could stall. The single number to watch is gross margin.

Consensus expects $2.23 EPS on $2.75B revenue — about 2.6x last quarter's EPS and about 18% above last quarter's revenue. Management did not give a formal Q2 EPS or revenue guide; the full-year guide is 'a few hundred million' of EBITDA growth. The signals suggest CE could beat consensus because the acetyl-chain pricing tailwind from the Middle East conflict is strong. The question is whether management raises or reaffirms the full-year EBITDA growth range. The one number to watch is Acetyl Chain's Q2 operating-profit step-up vs Q1; if it comes in below the 'little less than $200 million' the analyst cited, the beat case weakens.

Consensus for the upcoming Q3 is $1.83 EPS on $2.40B revenue. Management has not given a Q3 EPS guide, but the FY26 guide is $7.10-$7.35 EPS, 14.6%-14.9% adjusted EBITDA margin, and 8%-10.5% organic net revenue growth; the source material describes an implicit Q3 of roughly 7.5% organic growth and ~15% margin. The record backlog, 400% data-center pipeline growth, and ecosystem signals suggest Jacobs could beat. The question is whether management raises the full-year guide again and whether margins stay inside the raised range. The single most important number is organic net revenue growth: it was +9% last quarter, and if Q3 comes in below the implicit ~7.5%, the raised full-year guide could look aggressive.

Consensus is $1.61 EPS on $11.31B revenue. Management guided Q2 revenue to roughly $11.2B plus or minus $300M with about 56% gross margin, so consensus sits about $110M above the midpoint. AMD has beaten on revenue in 6 of the last 7 quarters, and ecosystem signals suggest they could beat again. The real question is what management does after the beat: does it raise the full-year trajectory, hold 56% margin, and confirm Helios production is on schedule for H2? The single most important number is server CPU revenue growth — management promised >70% year over year for Q2. If it comes in below that, the data center CPU story loses momentum even if total revenue beats.

Consensus expects $0.56 EPS on $396M revenue. Management guided Q2 EPS to $0.53–$0.57 and total revenue to –4% to –2% YoY. With seven straight quarterly beats and a cloud ecosystem that is beating and spending, TDC could land near the top of the $0.53–$0.57 EPS range. The question is whether management holds the FY26 total ARR growth guide of 2–4% and says anything about AI product contribution. The single number to watch is Q2 recurring revenue growth: it was +12% in Q1, the guide is –2% to flat, and a print below that range could put the full-year ARR target at risk.

Consensus for Q2 is -$0.07 EPS on $375M revenue, while management's FY2026 revenue guide is $1.5B-$1.7B and consensus at $1.52B sits near the low end. Q1 showed volume growth but only $3M adjusted EBITDA on $348M revenue, a 0.9% margin. Dow and Tesla signals suggest volumes could hold up, but cost inflation and import pressure could keep margins thin. The question for the call is whether management holds or raises the FY guide and whether surcharges restore EBITDA to positive territory. Watch adjusted EBITDA margin: if it stays below roughly 1% again, the FY guide could be at risk.

Consensus for the August 4 print is $0.37 EPS on $539M revenue. Management hasn’t given explicit Q2 revenue or EPS guidance; it reaffirmed 5–7% EPS growth through 2027 off adjusted 2024 EPS of $1.97 and a $1.7B capex plan. The company has beaten EPS estimates in 6 of the last 7 quarters, but the layer can sell beats. The question is whether management keeps the capex and rate-case path intact. Watch the capex pacing number: Q1 was $269M, so the next three quarters need to average roughly $477M to hit the $1.7B plan.

Consensus is for a -$0.13 EPS loss on essentially $0M of revenue. Management guided Q2 revenue to $50,000-$100,000, so the revenue guide sits above the consensus line. The signals suggest the company could hit that range if customer wafer deliveries land, but it has missed consensus in 6 straight quarters. The specific question is whether management can point to new data from the large IDM wafer runs or a path back to STMicroelectronics. The one number to watch is Q2 revenue: a print below $50,000 would fall short of management's own committed range.

Consensus is $0.50 EPS on $1.65B revenue for Q2, while management guided Q2 adjusted EBITDA to $220–250M and reaffirmed full-year net sales growth of 3–5%, adjusted EBITDA of $800–900M, and capex of $275–325M. The signals — record TSS margins, refrigerant aftermarket strength, and multi-year-high APM order velocity — suggest Chemours could beat. But Q1 pulled about $10M of Q2 demand forward, and APM is still recovering from an outage. The key question is whether management keeps the $800–900M EBITDA range and the H2 APM target of $30–40M. The number to watch is APM EBITDA: if the recovery stalls, the full-year guidance is the one at risk.

Consensus for this report is a loss of $0.35 per share on $1.73B revenue. Management's latest full-year 2026 adjusted EPS guide — adjusted earnings per share, a measure that strips out one-off items — is $4.80-$5.00, cut from $5.80-$6.00. Q1's Energy segment gross margin was 7.6% against a promised full-year range of high-9% to low-10%, so the signals suggest this could be a messy report rather than a clean beat. The key question is whether management defends the full-year margin and EPS guide. The key number to watch is Energy segment gross margin; anything below 7.6% could make the new guide look optimistic.

Consensus for the upcoming quarter — the average of analyst estimates — is $0.58 EPS on $3.46B revenue, versus $0.50 EPS on $3.3B revenue in Q1. Management's full-year guide is 4-5% organic growth, $935M-$975M adjusted EBITDA, and $2.90-$3.20 adjusted EPS; consensus FY EPS sits at the $3.05 midpoint. The signals suggest GXO could beat, but the muted sector reaction means the stock likely needs a clean beat and a maintained or raised guide. The question going in is whether Q2 organic growth holds at or above 4%; that is the single most important number to watch. Q1 came in at +4.1%, the low end of the range; if it slips below 4%, the guide could come under pressure. Also watch whether management raises the full-year EBITDA/EPS range again.

For the August 4 report, consensus is EPS of $0.63 on revenue of $410M, roughly 18% of TTM revenue in the seasonally weak quarter. Management has not given a Q2 guide; its FY2026 adjusted EPS guide is $4.83–$4.95, with adjusted net income of $306M–$314M, while December 2027 consensus EPS is $5.03, about 2% above the top of that FY guide. The signals — a signed data-centre contract, 6 late-stage large-load projects, and $27M of new-rate revenue last quarter — suggest OGS could meet or modestly beat consensus. The question is whether management updates the growth forecast or raises the FY guide. The number to watch is O&M growth: it was +8.6% year over year last quarter against a 3–4% target; another print in that range could outweigh an EPS beat.

Consensus is $0.89 EPS on $2.83B revenue; management guided ~$2.8B revenue, ~$0.88 EPS, and 62-63% gross margin. The ecosystem and purchase-commitment signals suggest they could beat the revenue guide by a small amount. The real question is whether management raises the full-year revenue target above $11.5B or the AI target above $3.5B. The one number to watch is gross margin: it came in at 62.4% last quarter, and a print below 62% could signal mix or pricing pressure.

Consensus expects Q2 EPS of -$0.02 on revenue of $7M. Management gave no specific Q2 guide; the full-year guide is revenue above 2025, FUEL CHEM flat, APC up, and SG&A of $14-15M. Strong gas-turbine demand and the large APC award suggest they could beat the revenue line, but the 1-of-3 beat record and Q1 FUEL CHEM weakness cut the other way. Listen for whether management confirms the $3-5M of near-term APC awards closed by end of Q2/early Q3, and for any new comment on the $75-100M data-center pipeline. That confirmation is the single most important item on this call.

Consensus for Q2 is a loss of $0.08 per share on $151 million of revenue. Management guided to $145-155 million of net sales and $10-13 million of adjusted EBITDA, so consensus sits slightly above the revenue midpoint and near the top of the range. Data-center award momentum and the raised cross-selling target suggest MEC could beat, but commercial-vehicle demand is still dragging. The key question is whether management raises the full-year ranges again — currently $590-620 million of revenue and $52-60 million of adjusted EBITDA. Watch data-center and critical power revenue: it was $23.6 million in Q1, and a sequential decline would make the >20%-of-2026-revenue target harder to reach.

Consensus is $1.40 EPS on $6.01B revenue for Q2. Management hasn't given a specific Q2 revenue or EPS guide in the source material, but it published a combined full-year outlook on June 9 and reaffirmed a $1B synergy target and a >30% dividend increase. The signals suggest DVN could beat — last quarter oil production hit the top end of guidance and capital came in 6% below midpoint — but the market mood in the sector is harsh: 73% beat rate yet only 35% of stocks rose. The number to watch is oil production versus guide, and whether management raises the full-year outlook now that Coterra integration is underway. A miss on production or a softer FY guide could outweigh an EPS beat.

Consensus for the upcoming quarter is $0.93 EPS on $177M revenue, versus $0.64 EPS reported last quarter. Management reaffirmed FY2026 revenue of $730M-$760M and adjusted EBITDA of $90M-$94M. The high book-to-bill and data-center bookings share suggest revenue could beat, but the EPS step is steep and Pioneer Power's margin drag could pull gross margin below the 26%-27% guide. The question is whether management raises or simply reaffirms the FY guide, and whether ODR organic growth turns positive after a -5.4% Q1. Watch gross margin: below 26% could make the adjusted EBITDA range hard to reach.

Consensus for the upcoming Q2 print is a loss of $0.13 per share on revenue of $2.74 billion. Management's explicit public guide is 2026 free cash flow of $1.9–$2.1 billion, raised last quarter from $1.2–$1.4 billion; no formal Q2 revenue guide appears in the source. Given six EPS beats in the last seven quarters, the PCF ramp, and the raised full-year FCF target, the signals suggest Lumen could beat again. The specific question is whether management raises the FCF guide again, reaffirms the adjusted-EBITDA inflection for 2026, and shows PCF revenue excluding one-time milestones staying near the roughly $184 million annualized pace from Q1. The one number to watch is PCF revenue excluding the $32 million one-time milestone — a sharp drop from that pace could make the backlog story feel less imminent.

Consensus expects $0.69 EPS on $361M revenue. Management guided Q2 revenue to $355M–$365M, and consensus sits slightly above the midpoint. With a 7-of-7 beat record, TSMC raising on AI demand, and Microsoft beating, the signals suggest they could beat again. The real question is whether management raises the second-half bar and whether gross margin holds near 74.4% after the roughly 200 bps non-cash warrant headwind. Watch gross margin: a print well below 74% could be read as pricing or mix trouble, not just the warrant.

Consensus for the upcoming report is $0.04 EPS on $103M revenue; the source shows no specific quarterly guidance from management, with the latest explicit targets being FY2025 FRE growth of 10-20% and the already-exceeded $40B FEEUM target. The signals — record quarterly leasing, a 7GW+ pipeline, and steady capital formation — suggest DBRG could beat fee revenue and fee-related earnings expectations, but the quality of the beat matters. The key question is whether management keeps the AI-era growth language and updates the SoftBank close timeline. The one number to watch is FRE excluding catch-up fees: it was $29M in Q3 2025 versus a $37M headline, and a similar gap in this report could make a headline beat look less durable.